The rates of p53 positivity according were as follows: AEH (0%), G1 endometrioid carcinoma (5.2%), G2 endometrioid carcinoma (10.3%), G3 endometrioid carcinoma (26.7%), clear cell carcinoma (27.3%), serous carcinoma (16.7%) and carcinosarcoma (18.2%). The gene discussed is TP53; the disease is clear cell adenocarcinoma.